Most Recent
Daily Telegraph can’t call ‘Witness X’ at Geoffrey Rush trial
The Daily Telegraph publisher Nationwide News has lost a bid to amend its defence in Geoffrey Rush's defamation case to include evidence from an unnamed witness it claimed would support the imputation that Rush engaged in sexual misconduct, with the judge saying the prejudice to Rush would be "manifest and palpable".
Second judge steps down ahead of Queensland Nickel trial
Billionaire Clive Palmer has succeeded in knocking a second judge off a case brought against him by the liquidators of failed Queensland Nickel, after arguing that a previous ruling disqualified him.
Otsuka defence threatened in Abilify patent case
The Commonwealth of Australia is weighing a bid to strike out Otsuka Pharmaceutical's defence as the government seeks lost subsidies after an almost seven-year long patent dispute over the antipsychotic drug, Abilify.
Ex-Norton Rose partner asks judge to recuse himself from spat with firm
A Federal Court judge has been asked to recuse himself from a legal dispute between Norton Rose Fulbright and a former employment partner who was terminated from the firm.
Melbourne University’s Trinity College sues to protect lucrative name
An education provider calling itself Trinity College Australia faces a lawsuit alleging it is duping consumers by trying to pass off as The University of Melbourne's famed residential college.
Another firm weighs class action over flammable cladding
A third law firm is investigating a possible class action to compensate property owners for the cost of removing highly combustible aluminium cladding, believed to be in the majority of buildings in Australia. 
Vittoria wins challenge to another Mondelez coffee machine patent
Australian coffee maker Vittoria Food & Beverage has won another challenge to a patent for a coffee pod system filed by a unit of Mondelez International.
Law firm looks at short-seller VGI in class action probe ‘twist’
Maurice Blackburn is investigating a possible class action after the share price of Corporate Travel Management plunged 27 percent on Wednesday, and will look at the role of VGI Partners in the sudden stock drop. 
Alphapharm slams Sanofi amendment delay in injunction battle
Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, despite knowing about the amendments for three years.
‘Disappointed’ judge decries delays in Sydney light rail class action
A judge has expressed frustration at the slow pace of the Sydney light rail class action, forcing both parties to commit to a timetable that will push the proceeding more rapidly towards a final hearing.